05/04/2023
ATTENTION: To all those who have been diagnosed with, know someone with, or care for someone with Alzheimer’s disease (or AD, the most common type of dementia). I strongly urge you to take the 30 seconds it takes to sign this petition that urges our administration and legislature to reconsider Medicare’s (Center for Medicare & Medicaid Services, or ‘CMS’) decision in 2022 to treat all of the newer AD ‘anti-amyloid treatments’ the same as the first that was controversially approved. This has a clear negative impact in allowing the three different medications to be considered individually (given their effectiveness and safety are all three very different) as well as restricting patients to only being able to get the treatments at a previously approved clinical trial site (an overwhelming percent of AD patients live some 2+ hours from treatment sites).
At the time of this decision, there was only one FDA approved anti-amyloid therapy; now there is another FDA approved therapy and soon a third will be.
The potential benefit to these medications is well studied, but even more so than the individual impact of these medications to a person who suffers with AD, is the negative impact to future research in a condition that went from 2003 through 2021 with no new treatments. These new treatments are the first to be considered to be ‘disease modifying’, which means having the potential to slow the progression in time.
This petition is sponsored and put on by the Alzheimer’s Association.
Sign the petition to President Biden urging his administration to cover FDA-approved Alzheimer's treatments now.
